
Align Technology (ALGN) Stock Forecast & Price Target
Align Technology (ALGN) Analyst Ratings
Bulls say
Align Technology's strong market position is underscored by its leading share in the clear aligner market, where it controls over 90% with its Invisalign product, which has been used on over 14 million patients since its launch. The company reported a year-over-year increase in teen case starts of 8.3% and a sequential growth in new Invisalign case starts to 647.8k, reflecting robust demand and positive trends across key markets. Additionally, the growth in Scanner/Services sales, which rose 5.6% year-over-year to $207.8 million, indicates a balanced revenue stream that enhances Align's overall financial health despite a slight miss in clear aligner sales.
Bears say
Align Technology has experienced weak operational performance, resulting in an adjusted EPS of $2.49, which fell short of the anticipated $2.57. Additionally, the company's adjusted gross margin percentage decreased by 40 basis points year-over-year to 70.5%, contributing to a significant decline in operating margin to 21.3%, both of which have raised concerns regarding revenue visibility and future profitability. Furthermore, the company management's downward revision of 2025 growth expectations for clear aligner volume and revenue reflects ongoing challenges in a weaker macro environment, indicating potential hurdles ahead for Align Technology's financial performance.
This aggregate rating is based on analysts' research of Align Technology and is not a guaranteed prediction by Public.com or investment advice.
Align Technology (ALGN) Analyst Forecast & Price Prediction
Start investing in Align Technology (ALGN)
Order type
Buy in
Order amount
Est. shares
0 shares